http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-884847-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dc2f7134efa50484bb359fda73782848
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-70
filingDate 1959-04-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1961-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber GB-884847-A
titleOfInvention Mercapto compounds
abstract The invention comprises amino - phenyl - mercapto-pyridines of the formula <FORM:0884847/IV (b)/1> and salts thereof, in which Ph represents a phenyl radical optionally bearing halogen, C1-6 alkyl, C1-6 alkoxy, amino or aminoalkylamino, especially tertiaryaminoalkylamino, substituents and R is an amino or aminoalkylamino group, preferably in the para-position. The compounds are prepared by treating 3-mercapto pyridine suitably in the form of its alkali-metal salt or in the presence of a condensing agent capable of forming a metal salt, with an appropriate halophenyl compound wherein the halogen atom is activated by an ortho or para nitro group such as p-nitro-chloro or p-nitro-bromo-benzene and reducing the resulting nitro compound, e.g. by nascent hydrogen or catalytic hydrogenation. Alternatively the compounds are prepared by reacting a 3-halo-pyridine with an amino-, acetylamino- or nitro-, mercapto-benzene, suitably in the form of a metal salt, or in the presence of a condensing agent forming such a salt and if necessary converting the acetylamino- or nitrosubstituent to an amino group. A free amino group in the product may be converted into an amino-alkylamino group by treating with an aryl-sulphonyl halide, e.g. p-toluenesulphochloride and reacting the resulting sulphonamide with an aminoalkylhalide, e.g. diethylaminoethyl chloride, in the presence of a condensing agent. Preferred products include p-amino-, o-amino, o : p-diamino, o-chloro-p-amino-, o-amino-p-chloro- and o-amino-p-methyl-, 3-phenylmercaptopyridine. The products are used pharmaceutically. Nitrophenylmercapto - pyridines corresponding to the above amino compounds and 3-(o-toluenesulphonylamino - phenylmercapto) - pyridine are obtained as intermediate products in the examples.ALSO:Pharmaceutical compositions having tranquilizing activity comprise compounds of the formula <FORM:0884847/VI/1> or salts thereof wherein Ph indicates a phenylene radical optionally bearing halogen, C1-6 alkyl C1-6 alkoxy, amine or aminoalkylamino, e.g. diethylaminoethylamino, substituents and R is an amino or aminoalkylamino radical (see Group IV (b)), together with a pharmaceutical carrier. The preparations suitably take the form of tablets, dragees, solutions, suspensions or emulsions and in addition to the carrier material may contain other therapeutically valuable substances.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2005526857-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6939885-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10364240-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9890148-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8030517-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0100158-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7335653-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8642808-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0100158-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7999109-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9035096-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7227035-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7582661-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7741519-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7420055-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8211896-B2
priorityDate 1958-04-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422154570
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419522661
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419511805
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3813610
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7969
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397808
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396401
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559592
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID429262061
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419502284
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID783
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11466
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2798187
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5333
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1049
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID429262062
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419547992
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416199511
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID153784612
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID153784613
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458427722
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410491760
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414868206
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID27691
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411961943
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7474
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13364

Total number of triples: 52.